Table 1 Patient characteristics
From: Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer
n (%) | |
|---|---|
Age | |
Mean±s.d. | 61.5±11 |
Range | 27–86 |
Sex | |
Male | 108 (55) |
Female | 88 (45) |
Tumour site | |
Colon, right-sided | 51 (26) |
Colon, left-sided | 98 (50) |
Rectum | 47 (24) |
Nodal status | |
N0 | 99 (50) |
N1 | 54 (28) |
N2 | 31 (16) |
N positive (not specified) | 12 (6) |
Tumour grade | |
Well to moderately differentiated | 167 (85) |
Poorly differentiated | 20 (10) |
Missing | 9 (5) |
VELIPI | |
0 | 67 (34) |
1 | 122 (62) |
Missing | 7 (4) |
Tumour stage | |
II | 99 (51) |
III | 97 (49) |
Adjuvant chemotherapy | |
5-Fluorouracil and folinic acid | 115 (59) |
No | 81 (41) |
Preoperative radiation therapy | |
Yes | 38 (19) |
No | 158 (81) |
